Apoptotic promoters and inhibitors in Alzheimer's disease: Who wins out?
- 22 February 2003
- journal article
- review article
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 27 (2) , 251-254
- https://doi.org/10.1016/s0278-5846(03)00020-4
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Additional use of immunostaining for active caspase 3 and cleaved actin and PARP fragments to detect apoptosis in patients with chronic heart failureJournal of Cardiac Failure, 2000
- Apoptosis and Alzheimer's DiseaseScience, 1998
- Redox Regulation of the Caspases during ApoptosisaAnnals of the New York Academy of Sciences, 1998
- Phosphorylated Forms of Activated Caspases Are Present in Cytosol From HL-60 Cells During Etoposide-Induced ApoptosisBlood, 1998
- A suicide note from Alzheimer disease neurons?Nature Medicine, 1998
- Caspases: the executioners of apoptosisBiochemical Journal, 1997
- Mechanisms of cell death in Alzheimer’s diseasePublished by Springer Nature ,1997
- A Role for 4‐Hydroxynonenal, an Aldehydic Product of Lipid Peroxidation, in Disruption of Ion Homeostasis and Neuronal Death Induced by Amyloid β‐PeptideJournal of Neurochemistry, 1997
- Mechanisms of Neuronal Death in Alzheimer's DiseaseBrain Pathology, 1996
- DNA damage and apoptosis in Alzheimer's disease: colocalization with c- Jun immunoreactivity, relationship to brain area, and effect of postmortem delayJournal of Neuroscience, 1996